Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 148, Issue -, Pages -Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2022.112735
Keywords
Autophagy; MiRNA; Lung cancer; Drug resistance
Ask authors/readers for more resources
Autophagy plays a crucial role in various diseases, and miRNAs can regulate cellular autophagy activity. Dysfunction of miRNAs is associated with the onset and drug resistance of lung cancer. Studying the interplay between miRNAs, autophagy, and drug resistance in lung cancer can lead to the development of new treatment interventions.
Autophagy is conserved cellular machinery that degrades un-usable proteins and cellular components and has a crucial role in the pathogenesis and drug resistance of various diseases such as lung cancer (LC). Multiple types of endogenous molecules (i.e. miRNAs) have been found to regulate multiple biological processes, such as autophagy. Dysfunction of these molecules is associated with the onset and progression of a variety of human malignancies. Several studies had shown that some miRNAs could mediate autophagy activity in LC cells, which would affect drug resistance as a major problem in LC therapy. Therefore, identifying the underlying molecular targets of miRNAs and their function in autophagy pathways could develop new treatment interventions for LC patients. In this review, we will summarize the interplay between miRNAs, autophagy, and drug resistance of LC patients, as well as the genes and molecular pathways that are involved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available